BlackRock, Inc. 13D and 13G filings for Rigel Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-25 1:48 pm Purchase |
2023-12-31 | 13G | Rigel Pharmaceuticals, Inc. RIGL |
BLACKROCK INC BLK |
1,519,808 8.700% |
51,701 (+3.52%) |
Filing |
| 2023-02-03 4:27 pm Sale |
2022-12-31 | 13G | Rigel Pharmaceuticals, Inc. RIGL |
BLACKROCK INC BLK |
1,468,106 8.500% |
-187,092 (-11.30%) |
Filing |
| 2022-02-01 5:08 pm Sale |
2021-12-31 | 13G | Rigel Pharmaceuticals, Inc. RIGL |
BLACKROCK INC BLK |
1,655,198 9.700% |
-94,144 (-5.38%) |
Filing |
| 2021-01-26 6:52 pm Purchase |
2020-12-31 | 13G | Rigel Pharmaceuticals, Inc. RIGL |
BLACKROCK INC BLK |
1,749,342 10.400% |
27,432 (+1.59%) |
Filing |
| 2020-07-10 10:39 am Purchase |
2020-06-30 | 13G | Rigel Pharmaceuticals, Inc. RIGL |
BLACKROCK INC BLK |
1,721,910 10.200% |
251,082 (+17.07%) |
Filing |